“…In GOPCABE (German Off‐Pump CABG in Elderly Trial), a German RCT including only patients aged >75 years, there was no significant difference in the primary composite end point of death, stroke, MI, or new renal replacement therapy (7.8% versus 8.2%, P =0.74) at 30 days41 and no differences in the individual components of the composite end point (Table 1). However, there was an increased number of repeat revascularizations with OPCAB (1.3% versus 0.4%, P =0.04), a finding also observed in CORONARY (0.7% versus 0.2%, P =0.01).…”